Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
JAMP-ROPINIROLE JAMP PHARMA CORPORATION Actual shortage 5.0MG Updated Report 2019-04-18 30025
JAMP-ROPINIROLE JAMP PHARMA CORPORATION Actual shortage 5.0MG Updated Report 2019-04-18 64287
JAMP-ROPINIROLE JAMP PHARMA CORPORATION Actual shortage 1.0MG Updated Report 2019-04-18 64282
JAMP-PIOGLITAZONE JAMP PHARMA CORPORATION Actual shortage 15MG Updated Report 2019-04-18 70089
JAMP-PIOGLITAZONE JAMP PHARMA CORPORATION Actual shortage 45MG Updated Report 2019-04-18 30031
JAMP-PIOGLITAZONE JAMP PHARMA CORPORATION Actual shortage 30MG Updated Report 2019-04-18 30028
JAMP-OXCARBAZEPINE JAMP PHARMA CORPORATION Actual shortage 600MG Updated Report 2019-04-18 64276
JAMP-OXCARBAZEPINE JAMP PHARMA CORPORATION Actual shortage 300MG Updated Report 2019-04-18 64271
JAMP-OXCARBAZEPINE JAMP PHARMA CORPORATION Actual shortage 150MG Updated Report 2019-04-18 64268
JAMP-LOSARTAN JAMP PHARMA CORPORATION Actual shortage 25MG Updated Report 2019-04-18 64259
JAMP-LOSARTAN JAMP PHARMA CORPORATION Actual shortage 25MG Updated Report 2019-04-18 64256
JAMP-LEVETIRACETAM JAMP PHARMA CORPORATION Actual shortage 750MG Updated Report 2019-04-18 64250
JAMP-LEVETIRACETAM JAMP PHARMA CORPORATION Actual shortage 500MG Updated Report 2019-04-18 64240
JAMP-LEVETIRACETAM JAMP PHARMA CORPORATION Actual shortage 250MG Updated Report 2019-04-18 64233
JAMP-CANDESARTAN JAMP PHARMA CORPORATION Actual shortage 32MG Updated Report 2019-04-18 64208
JAMP-CANDESARTAN JAMP PHARMA CORPORATION Actual shortage 16MG Updated Report 2019-04-18 64203
JAMP-CANDESARTAN JAMP PHARMA CORPORATION Actual shortage 8MG Updated Report 2019-04-18 64195
ALVESCO ASTRAZENECA CANADA INC Anticipated shortage 100MCG Updated Report 2019-04-18 80526
DOSTINEX PFIZER CANADA ULC Actual shortage 0.5MG Updated Report 2019-04-18 73569
EMEND TRI-PACK MERCK CANADA INC Anticipated shortage 125MG 80MG New Report 2019-04-18 81989
APO-MONTELUKAST APOTEX INC Actual shortage 10MG Updated Report 2019-04-18 78529
APO-VENLAFAXINE XR APOTEX INC Actual shortage 75.0MG New Report 2019-04-18 82022
APO-ROSUVASTATIN APOTEX INC Actual shortage 40MG New Report 2019-04-18 82019
APO-OLOPATADINE APOTEX INC Actual shortage 0.1% New Report 2019-04-18 82016
APO-ATORVASTATIN APOTEX INC Actual shortage 10MG New Report 2019-04-18 82013
ENGERIX-B GLAXOSMITHKLINE INC Actual shortage 10MCG Updated Report 2019-04-18 75189
ENGERIX-B GLAXOSMITHKLINE INC Actual shortage 20MCG Updated Report 2019-04-18 6511
VEPESID BRISTOL-MYERS SQUIBB CANADA Anticipated shortage 50MG Updated Report 2019-04-18 70228
0.9% SODIUM CHLORIDE INJECTION, USP BAXTER CORPORATION Actual shortage 900MG Updated Report 2019-04-18 80332
LACTATED RINGERS INJ USP BAXTER CORPORATION Actual shortage 310MG 20MG 30MG 600MG Updated Report 2019-04-18 80329
OLMETEC PLUS MERCK CANADA INC Anticipated shortage 12.5MG 40MG Updated Report 2019-04-18 80241
ACUVAIL ALLERGAN INC Actual shortage 0.45% Updated Report 2019-04-18 78953
BLEPHAMIDE OPHT SUSPENSION ALLERGAN INC Actual shortage 0.2% 10% Updated Report 2019-04-18 77342
SODIUM BICARBONATE INJECTION USP PFIZER CANADA ULC Resolved 84MG Updated Report 2019-04-18 63388
PRALUENT SANOFI-AVENTIS CANADA INC Resolved 75MG Updated Report 2019-04-18 80305
MONTELUKAST SANIS HEALTH INC Anticipated shortage 4MG New Report 2019-04-18 81981
MONTELUKAST SANIS HEALTH INC Anticipated shortage 5MG New Report 2019-04-18 81977
RIVA-OLMESARTAN LABORATOIRE RIVA INC Resolved 20MG Updated Report 2019-04-18 55204
RIVA-OLMESARTAN LABORATOIRE RIVA INC Resolved 40MG Updated Report 2019-04-18 55210
CANDESARTAN PRO DOC LIMITEE Resolved 16MG Updated Report 2019-04-18 76852
ERGONOVINE MALEATE INJECTION TELIGENT OU Resolved 0.25MG Updated Report 2019-04-18 78235
MED-EXEMESTANE GENERIC MEDICAL PARTNERS INC Resolved 25MG Updated Report 2019-04-18 78935
NEVANAC NOVARTIS PHARMACEUTICALS CANADA INC Resolved 0.1% Updated Report 2019-04-18 79161
LIPIDIL SUPRA BGP PHARMA ULC Actual shortage 160MG Updated Report 2019-04-18 80463
PHENOBARB PENDOPHARM DIVISION OF PHARMASCIENCE INC Resolved 60MG Updated Report 2019-04-17 70690
APO-FENO-SUPER APOTEX INC Actual shortage 100MG Updated Report 2019-04-17 15268
APO-LOSARTAN APOTEX INC Actual shortage 100MG Updated Report 2019-04-17 70523
OLMETEC MERCK CANADA INC Actual shortage 20MG Updated Report 2019-04-17 78421
METADOL-D PALADIN LABS INC Actual shortage 10MG Updated Report 2019-04-17 73749
ZITHROMAX FOR INTRAVENOUS INJECTION PFIZER CANADA ULC Actual shortage 500MG Updated Report 2019-04-17 72813

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
STATEX SYRUP 1MG/ML PALADIN LABS INC To be discontinued 1MG New Report 2019-04-18 81996
STATEX DPS 50MG/ML PALADIN LABS INC Discontinued Updated Report 2019-04-18 81954
RIVA-OLMESARTAN LABORATOIRE RIVA INC Discontinued 20MG Updated Report 2019-04-18 81926
RIVA-OLMESARTAN LABORATOIRE RIVA INC Discontinued 40MG Updated Report 2019-04-18 81929
ULTRAVIST 240 BAYER INC Discontinued 50% New Report 2019-04-17 81959